Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain

References

• Alam MI, Beg S, Samad A, et al. (2010). Strategy for effective brain drug delivery. Eur J Pharm Sci 40:385–403
   PubMed Web of Science ®Google Scholar
• Amorim CM, Netz DJA, Couto AG, et al. (2009). Stability-indicating LC-PDA method for determination of idebenone in nanoparticles based on chitosan and N-carboxymethylchitosan. Chromatographia 70:1411–15
   Web of Science ®Google Scholar
• Carbone C, Campisi A, Manno D, et al. (2014). The critical role of didodecyldimethylammonium bromide on physico-chemical, technological and biological properties of NLC. Colloids Surf B 121:1–10
   PubMed Web of Science ®Google Scholar
• Carbone C, Pignatello R, Musumeci T, Puglisi G. (2012a). Chemical and technological delivery systems for idebenone: a review of literature production. Expert Opin Drug Deliv 9:1377–92
   PubMed Web of Science ®Google Scholar
• Carbone C, Tomasello B, Ruozi B, et al. (2012b). Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design. Eur J Med Chem 49:110–17
   PubMed Web of Science ®Google Scholar
• Eldem T, Speiser P, Hincal A. (1991). Optimization of spray-dried and congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy. Pharm Res 8:47–54
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Evaluation of medicines for human use. London, 20 November 2008. Doc.Ref.:EMEA/387246/2009
   Google Scholar
• Fry DW, White C, Goldman DJ. (1978). Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem 90:809–15
   PubMed Web of Science ®Google Scholar
• Gasco MR. (1993). Method for producing solid lipid microspheres having a narrow size distribution. US Patent 52 50 236
   Google Scholar
• Gillis JC, Benefield P, McTavish D. (1994). Idebenone. A review of its pharmacodynamics and pharmacokinetic properties, and therapeutic use in age related cognitive disorders. Drugs Aging 5:133–52
   PubMed Web of Science ®Google Scholar
• Hatano T, Edamatsu R, Mori A, et al. (1989). Effects of the interaction of tannins with co-existing substances. VI. Effects of tannins and related polyphenols on superoxide anion radical, and on 1,1-diphenyl-pierylhydrazyl radical. Chem Pharm Bull 37:2016–21
   Web of Science ®Google Scholar
• ICH harmonized tripartite guideline. Stability testing of new drug substances and products Q1A(R2)
   Google Scholar
• Jacobs C, Muller RH. (2002). Production and characterization of a budesonide nanosuspension for pulmonary administration. Pharm Res 19:189–94
   PubMed Web of Science ®Google Scholar
• Jenning V, Schafer-Korting M, Gohla S. (2000). Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J Control Release 66:115–26
   PubMed Web of Science ®Google Scholar
• Khandadi P, Syed MA, Goparaboina S, Veerabrahma K. (2011). Brain specific delivery of pegylated indinavir submicron lipid emulsions. Eur J Pharm Sci 42:423–32
   PubMed Web of Science ®Google Scholar
• Liu Jie, Hu Wen, Chen Huabing, et al. (2007). Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm 328:191–5
   PubMed Web of Science ®Google Scholar
• Lockman PR, Koziara JM, Mumper RJ, Allen DD. (2004). Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target 12:635–41
   PubMed Web of Science ®Google Scholar
• Lockman PR, Oyewumi MO, Koziara JM, et al. (2003). Brain uptake of thiamine-coated nanoparticles. J Control Release 93:271–82
   PubMed Web of Science ®Google Scholar
• Montenegro L, Campisi A, Sarpietro MG, et al. (2011). In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain. Drug Dev Ind Pharm 37:737–46
   PubMed Web of Science ®Google Scholar
• Montenegro L, Carbone C, Condorelli G, et al. (2006). Effect of oil phase lipophilicity on in vitro drug release from O/W microemulsions with low surfactant concentration. Drug Dev Ind Pharm 32:539–48
   PubMed Web of Science ®Google Scholar
• Montenegro L, Trapani A, Latrofa A, Puglisi G. (2012). In vitro evaluation on a model of blood brain barrier of idebenone-loaded solid lipid nanoparticles. J Nanosci Nanotech 12:330–7
   PubMed Web of Science ®Google Scholar
• Morris R. (1984). Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47–60
   PubMed Web of Science ®Google Scholar
• Muller RH, Mader K, Gohla S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery- a review of the state of the art. Eur J Pharm Biopharm 50:161–77
   PubMed Web of Science ®Google Scholar
• Muller RH, Runge SA, Ravelli V. (1998). German patent application DE19819273A1
   Google Scholar
• Osterwald HP. (1990). Pharmaceutic development: mesalazine. Scand J Gastroenterol 25:43–6
   Web of Science ®Google Scholar
• Salunkhe SS, Bhatia NM, Thorat JD, et al. (2014). Formulation, development and evaluation of ibuprofen loaded nanoemulsion prepared by nanoprecipitation technique: use of factorial design approach as a tool of optimization methodology. J Pharm Invest 44:1–18
   Google Scholar
• Souto EB, Muller RH. (2006). Polymorphic behaviour of Compritol 888 ATO as bulk lipid and as SLN and NLC. J Microencapsul 23:377–88
   PubMed Web of Science ®Google Scholar
• Speiser P. (1990). Lipid nanopellets als Tragersystem fur Arzneimittel zur peroralen Anwendung. European Patent EP 01 67 825
   Google Scholar
• Stancampiano AHS, Acquaviva R, Campisi A, et al. (2006). Technological and biological characterization of idebenone-loaded solid lipid nanoparticles prepared by a modified solvent injection technique. J Biomed Nanotechnol 2:253–70
   Web of Science ®Google Scholar
• Suno M, Nagaoka A. (1984). Inhibition of lipid peroxidation by a novel compound, idebenone (CV-2619). Jap J Pharmacol 35:196–8
   PubMedGoogle Scholar
• Teeranachaideekul V, Müller RH, Junyaprasert VB. (2007a). Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC) effects of formulation parameters on physicochemical stability. Int J Pharm 340:198–206
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Souto EB, Junyaprasert VB, Muller RH. (2007b). Cetyl palmitate-based NLC for topical delivery of Coenzyme Q10-development, physicochemical characterization and in vitro release study. Eur J Pharm Biopharm 67:141–8
   PubMed Web of Science ®Google Scholar
• Tiwari SB, Amiji MM. (2006). Improved oral delivery of paclitaxel following administration in nanoemulsion formulations. J Nanosci Nanotechnol 6:3215–21
   PubMed Web of Science ®Google Scholar
• Tosi G, Costantino L, Ruozi B, et al. (2008). Polymeric nanoparticles for the drug delivery to the central nervous system. Expert Opin Drug Deliv 5:155–74
   PubMed Web of Science ®Google Scholar
• Vyas TK, Shahiwala A, Amiji MM. (2008). Improved oral bioavailability and brain transport of saquinavir upon administration in novel nanoemulsion formulations. Int J Pharm 347:93–101
   PubMed Web of Science ®Google Scholar
• Watts PJ, Illum L. (1997). Colonic drug delivery. Drug Dev Ind Pharm 23:893–913
   Web of Science ®Google Scholar
• Wong HL, Wu XY, Bendayan R. (2012). Nanotechnological advances for the delivery of CNS therapeutics. Adv Drug Deliv Rev 64:686–700
   PubMed Web of Science ®Google Scholar
• Yamada N, Hattori A, Hayashi T, et al. (2004). Improvement of scopolamine induced memory impairment by Z-ajozene in the water maze in mice. Pharmacol Biochem Behav 78:787–91
   PubMed Web of Science ®Google Scholar
• Yoshiyuki K, Michinori K, Tadato T, et al. (1981). Studies on Scutellariae Radix. IV. Effects on lipid peroxidation in rat liver. Chem Pharm Bull 29:2610–17
   PubMed Web of Science ®Google Scholar
• Zhang P, Chen L, Gu W, et al. (2007). In vitro and in vivo evaluation of donepezil sustained release microparticles for the treatment of Alzheimer’s disease. Biomaterials 28:1882–8
   PubMed Web of Science ®Google Scholar